ABSTRACT
BACKGROUND: The extent to which prenatal low-level mercury (Hg) exposure through maternal fish intake and heavy metals exposure affect children's neurodevelopment is controversial and may appear in the long term. In 2007, a prospective cohort, the Northern Adriatic Cohort II (NAC-II), was established to investigate the association between prenatal Hg exposure from maternal fish consumption and child neurodevelopment. The study enrolled 900 pregnant women, and 632 and 470 children underwent neurodevelopmental evaluation at 18 and 40 months of age, respectively. The NAC-II cohort is a part of the Mediterranean cohort in the "Public health impact of long-term, low-level, mixed element exposure in susceptible population strata" project. METHODS: This protocol describes the follow-up assessment of the effects of prenatal low level Hg and other heavy metals exposure on the developing nervous system of the children born within the NAC-II who reached the age of 7 years. Child diet components are estimated through a Diet Diary. Child hair and urine are collected for determination of Hg level. In addition, levels of other potentially neurotoxic metals, namely Manganese, Cadmium, Lead, Arsenic, and Selenium, are also measured in the same matrices. DISCUSSION: This protocol extends to the first years of schooling age the evaluation of the neurotoxicant effect of Mercury and of the other heavy metals on children's neurodevelopment, adjusting for the potential confounders, such as the lifestyles and social economic status of children's families. Longitudinal analysis of neurodevelopment, assessed in different ages (18 months, 40 months, and 7 years), are performed.
Subject(s)
Maternal Nutritional Physiological Phenomena , Metals, Heavy/toxicity , Methylmercury Compounds/toxicity , Neurodevelopmental Disorders/epidemiology , Prenatal Exposure Delayed Effects , Adult , Animals , Child , Child, Preschool , Diet Surveys , Female , Fishes , Follow-Up Studies , Food Contamination , Hair/chemistry , Humans , Infant , Italy/epidemiology , Male , Metals, Heavy/analysis , Metals, Heavy/urine , Methylmercury Compounds/analysis , Methylmercury Compounds/urine , Pregnancy , Prospective StudiesABSTRACT
Platelets are the second most abundant cell type in blood and are essential for maintaining haemostasis. Their count and volume are tightly controlled within narrow physiological ranges, but there is only limited understanding of the molecular processes controlling both traits. Here we carried out a high-powered meta-analysis of genome-wide association studies (GWAS) in up to 66,867 individuals of European ancestry, followed by extensive biological and functional assessment. We identified 68 genomic loci reliably associated with platelet count and volume mapping to established and putative novel regulators of megakaryopoiesis and platelet formation. These genes show megakaryocyte-specific gene expression patterns and extensive network connectivity. Using gene silencing in Danio rerio and Drosophila melanogaster, we identified 11 of the genes as novel regulators of blood cell formation. Taken together, our findings advance understanding of novel gene functions controlling fate-determining events during megakaryopoiesis and platelet formation, providing a new example of successful translation of GWAS to function.
Subject(s)
Blood Platelets/cytology , Hematopoiesis/genetics , Megakaryocytes/cytology , Animals , Blood Platelets/metabolism , Cell Size , Drosophila Proteins/genetics , Drosophila melanogaster/genetics , Europe , Gene Expression Profiling , Gene Silencing , Genome, Human/genetics , Genome-Wide Association Study , Humans , Megakaryocytes/metabolism , Platelet Count , Protein Interaction Maps , Transcription, Genetic/genetics , Zebrafish/genetics , Zebrafish Proteins/geneticsABSTRACT
Leber's hereditary optic neuropathy is a maternally inherited blinding disease caused as a result of homoplasmic point mutations in complex I subunit genes of mitochondrial DNA. It is characterized by incomplete penetrance, as only some mutation carriers become affected. Thus, the mitochondrial DNA mutation is necessary but not sufficient to cause optic neuropathy. Environmental triggers and genetic modifying factors have been considered to explain its variable penetrance. We measured the mitochondrial DNA copy number and mitochondrial mass indicators in blood cells from affected and carrier individuals, screening three large pedigrees and 39 independently collected smaller families with Leber's hereditary optic neuropathy, as well as muscle biopsies and cells isolated by laser capturing from post-mortem specimens of retina and optic nerves, the latter being the disease targets. We show that unaffected mutation carriers have a significantly higher mitochondrial DNA copy number and mitochondrial mass compared with their affected relatives and control individuals. Comparative studies of fibroblasts from affected, carriers and controls, under different paradigms of metabolic demand, show that carriers display the highest capacity for activating mitochondrial biogenesis. Therefore we postulate that the increased mitochondrial biogenesis in carriers may overcome some of the pathogenic effect of mitochondrial DNA mutations. Screening of a few selected genetic variants in candidate genes involved in mitochondrial biogenesis failed to reveal any significant association. Our study provides a valuable mechanism to explain variability of penetrance in Leber's hereditary optic neuropathy and clues for high throughput genetic screening to identify the nuclear modifying gene(s), opening an avenue to develop predictive genetic tests on disease risk and therapeutic strategies.
Subject(s)
DNA, Mitochondrial/genetics , Mitochondrial Turnover/genetics , Optic Atrophy, Hereditary, Leber/diagnosis , Optic Atrophy, Hereditary, Leber/genetics , Penetrance , Adolescent , Adult , Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Pedigree , Young AdultABSTRACT
The mitochondrial (mt) DNA depletion syndromes (MDDS) are genetic disorders characterized by a severe, tissue-specific decrease of mtDNA copy number, leading to organ failure. There are two main clinical presentations: myopathic (OMIM 609560) and hepatocerebral (OMIM 251880). Known mutant genes, including TK2, SUCLA2, DGUOK and POLG, account for only a fraction of MDDS cases. We found a new locus for hepatocerebral MDDS on chromosome 2p21-23 and prioritized the genes on this locus using a new integrative genomics strategy. One of the top-scoring candidates was the human ortholog of the mouse kidney disease gene Mpv17. We found disease-segregating mutations in three families with hepatocerebral MDDS and demonstrated that, contrary to the alleged peroxisomal localization of the MPV17 gene product, MPV17 is a mitochondrial inner membrane protein, and its absence or malfunction causes oxidative phosphorylation (OXPHOS) failure and mtDNA depletion, not only in affected individuals but also in Mpv17-/- mice.
Subject(s)
DNA, Mitochondrial/genetics , Intracellular Membranes/metabolism , Liver Diseases/genetics , Membrane Proteins/genetics , Mitochondria/metabolism , Mutation , Amino Acid Sequence , Animals , Cells, Cultured , Chromosomes, Human, Pair 2 , Cloning, Molecular , Female , Fluorescent Antibody Technique , Humans , Male , Membrane Proteins/chemistry , Mice , Molecular Sequence Data , Pedigree , SyndromeABSTRACT
BACKGROUND: The ancient Silk Road has been a trading route between Europe and Central Asia from the 2(nd) century BCE to the 15(th) century CE. While most populations on this route have been characterized, the genetic background of others remains poorly understood, and little is known about past migration patterns. The scientific expedition "Marco Polo" has recently collected genetic and phenotypic data in six regions (Georgia, Armenia, Azerbaijan, Uzbekistan, Kazakhstan, Tajikistan) along the Silk Road to study the genetics of a number of phenotypes. RESULTS: We characterized the genetic structure of these populations within a worldwide context. We observed a West-East subdivision albeit the existence of a genetic component shared within Central Asia and nearby populations from Europe and Near East. We observed a contribution of up to 50% from Europe and Asia to most of the populations that have been analyzed. The contribution from Asia dates back to ~25 generations and is limited to the Eastern Silk Road. Time and direction of this contribution are consistent with the Mongolian expansion era. CONCLUSIONS: We clarified the genetic structure of six populations from Central Asia and suggested a complex pattern of gene flow among them. We provided a map of migration events in time and space and we quantified exchanges among populations. Altogether these novel findings will support the future studies aimed at understanding the genetics of the phenotypes that have been collected during the Marco Polo campaign, they will provide insights into the history of these populations, and they will be useful to reconstruct the developments and events that have shaped modern Eurasians genomes.
Subject(s)
Gene Flow , Human Migration , Asian People/genetics , Commonwealth of Independent States , Homozygote , Humans , Phenotype , Polymorphism, Single Nucleotide , Principal Component Analysis , Sequence Analysis, DNA , White People/geneticsABSTRACT
We investigated two male infant patients who were given a diagnosis of progressive mitochondrial encephalomyopathy on the basis of clinical, biochemical, and morphological features. These patients were born from monozygotic twin sisters and unrelated fathers, suggesting an X-linked trait. Fibroblasts from both showed reduction of respiratory chain (RC) cIII and cIV, but not of cI activities. We found a disease-segregating mutation in the X-linked AIFM1 gene, encoding the Apoptosis-Inducing Factor (AIF) mitochondrion-associated 1 precursor that deletes arginine 201 (R201 del). Under normal conditions, mature AIF is a FAD-dependent NADH oxidase of unknown function and is targeted to the mitochondrial intermembrane space (this form is called AIF(mit)). Upon apoptogenic stimuli, a soluble form (AIF(sol)) is released by proteolytic cleavage and migrates to the nucleus, where it induces "parthanatos," i.e., caspase-independent fragmentation of chromosomal DNA. In vitro, the AIF(R201 del) mutation decreases stability of both AIF(mit) and AIF(sol) and increases the AIF(sol) DNA binding affinity, a prerequisite for nuclear apoptosis. In AIF(R201 del) fibroblasts, staurosporine-induced parthanatos was markedly increased, whereas re-expression of AIF(wt) induced recovery of RC activities. Numerous TUNEL-positive, caspase 3-negative nuclei were visualized in patient #1's muscle, again indicating markedly increased parthanatos in the AIF(R201 del) critical tissues. We conclude that AIF(R201 del) is an unstable mutant variant associated with increased parthanatos-linked cell death. Our data suggest a role for AIF in RC integrity and mtDNA maintenance, at least in some tissues. Interestingly, riboflavin supplementation was associated with prolonged improvement of patient #1's neurological conditions, as well as correction of RC defects in mutant fibroblasts, suggesting that stabilization of the FAD binding in AIF(mit) is beneficial.
Subject(s)
Apoptosis Inducing Factor/genetics , Apoptosis , Genes, X-Linked , Mitochondrial Encephalomyopathies/genetics , Mutation/genetics , Apoptosis Inducing Factor/metabolism , Caspase 3/metabolism , Computer Simulation , DNA Primers/chemistry , DNA, Mitochondrial/genetics , DNA, Mitochondrial/metabolism , Dietary Supplements , Electron Transport/physiology , Female , Fibroblasts/cytology , Fibroblasts/drug effects , Fibroblasts/metabolism , Flavin-Adenine Dinucleotide/metabolism , Humans , In Situ Nick-End Labeling , Infant, Newborn , Magnetic Resonance Imaging , Male , Mitochondrial Encephalomyopathies/metabolism , Mitochondrial Encephalomyopathies/pathology , Muscle, Skeletal/cytology , Muscle, Skeletal/drug effects , Muscle, Skeletal/metabolism , Nervous System Diseases/drug therapy , Nervous System Diseases/etiology , Pedigree , Poly (ADP-Ribose) Polymerase-1 , Poly(ADP-ribose) Polymerases/metabolism , Protein Conformation , Riboflavin/administration & dosage , Staurosporine/pharmacology , Twins, MonozygoticABSTRACT
Respiratory insufficiency is the major cause of morbidity and mortality in patients affected by cystic fibrosis (CF). An excessive neutrophilic inflammation, mainly orchestrated by the release of IL-8 from bronchial epithelial cells and amplified by chronic bacterial infection with Pseudomonas aeruginosa, leads to progressive tissue destruction. The anti-inflammatory drugs presently used in CF patients have several limitations, indicating the need for identifying novel molecular targets. To address this issue, we preliminarily studied the association of 721 single nucleotide polymorphisms from 135 genes potentially involved in signal transduction implicated in neutrophil recruitment in a cohort of F508del homozygous CF patients with either severe or mild progression of lung disease. The top ranking association was found for a nonsynonymous polymorphism of the phospholipase C-ß3 (PLCB3) gene. Studies in bronchial epithelial cells exposed to P. aeruginosa revealed that PLCB3 is implicated in extracellular nucleotide-dependent intracellular calcium signaling, leading to activation of the protein kinase Cα and Cß and of the nuclear transcription factor NF-κB p65. The proinflammatory pathway regulated by PLCB3 acts by potentiating the Toll-like Receptors' signaling cascade and represents an interesting molecular target to attenuate the excessive recruitment of neutrophils without completely abolishing the inflammatory response.
Subject(s)
Cystic Fibrosis/genetics , Epithelial Cells/metabolism , Interleukin-8/genetics , Phospholipase C beta/genetics , Adenosine Triphosphate/pharmacology , Calcium/metabolism , Cell Line, Transformed , Cystic Fibrosis/metabolism , Cystic Fibrosis/pathology , Enzyme Activation , Epithelial Cells/microbiology , Gene Expression/drug effects , Gene Frequency , Genotype , Green Fluorescent Proteins/genetics , Green Fluorescent Proteins/metabolism , Host-Pathogen Interactions , Humans , Interleukin-8/metabolism , Isoenzymes/genetics , Isoenzymes/metabolism , Lung Diseases/genetics , Lung Diseases/metabolism , Lung Diseases/pathology , Microscopy, Fluorescence , Phospholipase C beta/metabolism , Polymorphism, Single Nucleotide , Protein Kinase C/genetics , Protein Kinase C/metabolism , Protein Kinase C beta , Pseudomonas aeruginosa/physiology , RNA Interference , Toll-Like Receptors/genetics , Toll-Like Receptors/metabolism , Transcription Factor RelA/genetics , Transcription Factor RelA/metabolismSubject(s)
Analgesics, Opioid/pharmacokinetics , Analgesics, Opioid/therapeutic use , Catechol O-Methyltransferase/genetics , Cytochrome P-450 CYP3A/metabolism , Drug Resistance/physiology , Aged , Cancer Pain/drug therapy , Endometrial Neoplasms/complications , Female , Genotype , Humans , Polymorphism, Single NucleotideABSTRACT
Despite the excellent survival rate of Wilms tumor (WT) patients, only approximately one-half of children who suffer tumor recurrence reach second durable remission. This underlines the need for novel markers to optimize initial treatment. We investigated 77 tumors using Illumina 370CNV-QUAD genotyping BeadChip arrays and compared their genomic profiles to detect copy number (CN) abnormalities and allelic ratio anomalies associated with the following clinicopathological variables: relapse (yes vs. no), age at diagnosis (≤ 24 months vs. >24 months), and disease stage (low stage, I and II, vs. high stage, III and IV). We found that CN gains at chromosome region 1q21.1-q31.3 were significantly associated with relapse. Additional genetic events, including allelic imbalances at chromosome arms 1p, 1q, 3p, 3q, and 14q were also found to occur at higher frequency in relapsing tumors. Interestingly, allelic imbalances at 1p and 14q also showed a borderline association with higher tumor stages. No genetic events were found to be associated with age at diagnosis. This is the first genome wide analysis with single nucleotide polymorphism (SNP) arrays specifically investigating the role of genetic anomalies in predicting WT relapse on cases prospectively enrolled in the same clinical trial. Our study, besides confirming the role of 1q gains, identified a number of additional candidate genetic markers, warranting further molecular investigations.
Subject(s)
Genome, Human , Wilms Tumor/genetics , Adolescent , Allelic Imbalance , Child , Child, Preschool , Chromosome Aberrations , DNA Copy Number Variations , Female , Genetic Markers/genetics , Genetic Predisposition to Disease , Genome-Wide Association Study , Humans , Infant , Kaplan-Meier Estimate , Male , Polymorphism, Single Nucleotide , Prospective Studies , RecurrenceABSTRACT
In two siblings we found a mitochondrial encephalomyopathy, characterized by developmental delay, hemiplegia, convulsions, asymmetrical brain atrophy, and low cytochrome c oxidase (COX) activity in skeletal muscle. The disease locus was identified on chromosome 2 by homozygosity mapping; candidate genes were prioritized for their known or predicted mitochondrial localization and then sequenced in probands and controls. A homozygous nonsense mutation in the KIAA0971 gene segregated with the disease in the proband family. The corresponding protein is known as fas activated serine-threonine kinase domain 2, FASTKD2. Confocal immunofluorescence colocalized a tagged recombinant FASTKD2 protein with mitochondrial markers, and membrane-potential-dependent in vitro mitochondrial import was demonstrated in isolated mitochondria. In staurosporine-induced-apoptosis experiments, decreased nuclear fragmentation was detected in treated mutant versus control fibroblasts. In conclusion, we found a loss-of-function mutation in a gene segregating with a peculiar mitochondrial encephalomyopathy associated with COX deficiency in skeletal muscle. The corresponding protein is localized in the mitochondrial inner compartment. Preliminary data indicate that FASTKD2 plays a role in mitochondrial apoptosis.
Subject(s)
Codon, Nonsense , Cytochrome-c Oxidase Deficiency/genetics , Genetic Predisposition to Disease , Mitochondrial Encephalomyopathies/genetics , Muscle, Skeletal/metabolism , Protein Serine-Threonine Kinases/genetics , Animals , COS Cells , Chlorocebus aethiops , Cytochrome-c Oxidase Deficiency/metabolism , Female , HeLa Cells , Humans , Infant , Infant, Newborn , Male , Mitochondria/metabolism , Mitochondrial Encephalomyopathies/metabolism , Pedigree , SiblingsABSTRACT
Cytochrome c oxidase (COX) deficiency, one of the most common respiratory-chain defects in humans, has been associated with mutations in either mitochondrial DNA genes or nucleus-encoded proteins that are not part in but promote the biogenesis of COX. Mutations of nucleus-encoded structural subunits were sought for but never found in COX-defective patients, leading to the conjecture that they may be incompatible with extra-uterine survival. We report a disease-associated mutation in one such subunit, COX6B1. Nuclear-encoded COX genes should be reconsidered and included in the diagnostic mutational screening of human disorders related to COX deficiency.
Subject(s)
Brain Diseases, Metabolic, Inborn/enzymology , Brain Diseases, Metabolic, Inborn/genetics , Cytochrome-c Oxidase Deficiency/enzymology , Cytochrome-c Oxidase Deficiency/genetics , Electron Transport Complex IV/genetics , Point Mutation , Amino Acid Sequence , Amino Acid Substitution , Base Sequence , Brain/pathology , Brain Diseases, Metabolic, Inborn/pathology , Cell Nucleus/enzymology , Cell Nucleus/genetics , Child , Cytochrome-c Oxidase Deficiency/pathology , Electron Transport Complex IV/chemistry , Female , Genetic Complementation Test , Haplotypes , HeLa Cells , Humans , Infant , Magnetic Resonance Imaging , Male , Models, Molecular , Molecular Sequence Data , Pedigree , Protein Conformation , RNA Interference , Sequence Homology, Amino AcidSubject(s)
Carbamazepine/adverse effects , Genotype , Polymorphism, Single Nucleotide , Purpura, Thrombocytopenic , Carbamazepine/administration & dosage , Child , Female , Humans , Purpura, Thrombocytopenic/blood , Purpura, Thrombocytopenic/chemically induced , Purpura, Thrombocytopenic/genetics , Purpura, Thrombocytopenic/pathologyABSTRACT
BACKGROUND: Coffin-Lowry syndrome (CLS) is a syndromic form of X-linked intellectual disability, in which specific associated facial, hand, and skeletal abnormalities are diagnostic features. METHODS: In the present study, an unreported missense genetic variant of the ribosomal S6 kinase 2 (RSK2) gene has been identified, by next-generation sequencing, in two related males with two different phenotypes of intellectual disability (ID) and peculiar facial dysmorphisms. We performed functional studies on this variant and another one, already reported in the literature, involving the same amino acid residue but, to date, without an efficient characterization. RESULTS: Our study demonstrated that the two variants involving residue 189 significantly impaired its kinase activity. CONCLUSIONS: We detected a loss-of-function RSK2 mutation with loss in kinase activity in a three-generation family with an X-linked ID.
ABSTRACT
The study of two different Italian isolated populations was combined with a metabonomic approach to better understand tubular handling of amino acids. Levels of amino acids and metabolites have been analyzed by Nucleic Magnetic Resonance and expressed as ratio vs urinary creatinine concentration (mmol/mol). For most of the amino acids there is an age-related U shape pattern of excretion, with the peaks during childhood and old age, and a significant reduction in the adult age. Hierarchical cluster analysis has clearly identified three groups clustering the same amino acids: His, Thr and Ala (group one); Gly and Phe (group two) and a third larger one. Results have been further confirmed by factor and regression analysis, and used to confirm and, in some cases, infer new amino acids networks. As a matter of facts, the identification of strong evidences for clustering of urine excretion of several neutral amino acids suggests the predominant impact of relevant and common transporters.
Subject(s)
Amino Acids/urine , Metabolomics , Population Groups , Adolescent , Adult , Age Factors , Aged , Amino Acids/chemistry , Child , Child, Preschool , Female , Humans , Italy , Male , Middle Aged , Rural Population , Young AdultABSTRACT
PURPOSE: To measure epidermal thickness by using skin ultrasonography (US) in a series of healthy control subjects and obligate carriers for the worldwide most frequent form of congenital hearing loss owing to the mutated alleles of the connexin 26 gene (GJB2). MATERIALS AND METHODS: The patent for the protocol, coupled with a new sonographic probe specifically designed to analyze epidermal thickness and a dedicated algorithm to classify individuals in groups, is pending. Institutional ethics committee approval and patient consent were obtained. After a preliminary study in 23 subjects aimed to define the best body site and instrument and protocol for US, a total of 303 individuals (237 healthy subjects, 51 carriers, and 15 homozygotes) were tested at midline forehead by using a linear large-band probe with a frequency ranging from 6 to 15 MHz to determine epidermal thickness. Variance and linear regression analyses were performed. Regression coefficients were then used to obtain measurements of thickness corrected for age and sex. RESULTS: GJB2 obligate carriers had a significant increase in epidermal thickness compared with control subjects. GJB2 status explains about 50.0% of this variability, whereas an additional 25.0% is explained by sex and age. Results led to the development of a possible screening protocol with a 98.0% sensitivity and 92.8% specificity in subjects aged 2080 years, with a likelihood ratio of a positive test of 14:1. Even better results (100% sensitivity and 98.9% specificity) were obtained in an analysis of people of only reproductive age. CONCLUSION: Epidermal thickening in the white population owing to GJB2 carrier status can be detected by using US. This measurement could provide a simple, noninvasive, rapid, and sensitive test for carrier screening.
Subject(s)
Connexins/genetics , Epidermis/diagnostic imaging , Genetic Testing/methods , Hearing Loss/epidemiology , Hearing Loss/genetics , Risk Assessment/methods , Ultrasonography/statistics & numerical data , Adult , Aged , Aged, 80 and over , Connexin 26 , Female , Genetic Predisposition to Disease/genetics , Heterozygote , Humans , Incidence , Italy/epidemiology , Male , Mass Screening/methods , Middle Aged , Reproducibility of Results , Risk Factors , Sensitivity and Specificity , Young AdultABSTRACT
BACKGROUND: Defects of integrin alpha(IIb)beta(3) are typical of Glanzmann's thrombasthenia, an inherited autosomal recessive bleeding disorder characterized by the failure of platelets to aggregate in response to all physiological agonists, but with no abnormalities in the number or size of platelets. Although large heterogeneity has been described for Glanzmann's thrombasthenia, no family has so far been described as having an autosomal dominant form of this disease. DESIGN AND METHODS: We describe two Italian families with moderate thrombocytopenia with large platelets, defective platelet function and moderate/severe mucocutaneous bleeding, transmitted as an autosomal dominant trait and associated with a novel integrin beta(3)-gene (ITGB3) mutation. RESULTS: The characteristics of our families are moderate macrothrombocytopenia and defective platelet function associated with a mild reduction of surface alpha(Ib) beta(3), impaired platelet aggregation to physiological agonists but not to ristocetin, normal clot retraction, reduced fibrinogen binding and expression of activated alpha(IIb)beta(3) upon stimulation, normal platelet adhesion to immobilized fibrinogen but reduced platelet spreading and tyrosine phosphorylation, indicating defective alpha(IIb)beta(3)-mediated outside-in signaling. Molecular analysis revealed a novel mutation of ITGB3 that determines an in-frame deletion producing the loss of amino acids 647-686 of the betaTD ectodomain of integrin beta(3). Haplotype analysis indicated that the two families inherited the mutation from a common ancestral chromosome. CONCLUSIONS: This novel autosomal dominant macrothrombocytopenia associated with platelet dysfunction raises interesting questions about the role of integrin beta(3), and its betaTD domain, in platelet formation and function.
Subject(s)
Blood Platelets/metabolism , Integrin beta3/genetics , Point Mutation , Thrombocytopenia/genetics , Base Sequence , Blood Platelets/pathology , Blood Platelets/ultrastructure , Blotting, Western , DNA Mutational Analysis , Family Health , Female , Flow Cytometry , Genes, Dominant , Humans , Italy , Male , Membrane Glycoproteins/metabolism , Microscopy, Electron , Pedigree , Platelet Aggregation , Thrombocytopenia/blood , Thrombocytopenia/pathologySubject(s)
Embolism, Paradoxical/etiology , Intestinal Polyposis/complications , Intracranial Embolism/etiology , Telangiectasia, Hereditary Hemorrhagic/complications , Adult , Arteriovenous Malformations/diagnostic imaging , Arteriovenous Malformations/therapy , Brain Ischemia/etiology , Chromosomes, Human, Pair 18/genetics , Echocardiography, Transesophageal , Embolization, Therapeutic , Epistaxis/etiology , Family Health , Humans , Intestinal Polyposis/genetics , Introns , Lod Score , Male , Pulmonary Artery/abnormalities , Smad4 Protein/genetics , Telangiectasia, Hereditary Hemorrhagic/genetics , Thalamus/blood supply , Ultrasonography, Doppler, TranscranialABSTRACT
The objective of this study was to estimate the prevalence of hearing impairment in four genetically isolated Italian villages (Carlantino, Campora, Gioi-Cardile, and Stoccareddo), 1682 subjects were recruited from all the individuals participating in a multidisciplinary study. They underwent otoscopy and pure-tone audiometry and completed a questionnaire. The audiological data show that the percentage of impaired people increases with age and in particular becomes relevant aged over 40. For this reason we decided to compare the PTA values of individuals aged 40 or older. The PTA values of Stoccareddo and Carlantino are statistically different from PTAs of the other villages. Campora and Gioi-Cardile, both located within the Cilento National Park, have similar middle-low frequency PTA values while some differences are present at high frequencies. Using pedigrees it was possible to calculate the heritability of the trait. For Carlantino and Gioi-Cardile the percentage of the phenotype variation attributable to genetic variation is not significant, while for Campora the heritability value is 0.49 (p = 0.01) suggesting that genetic factors may have an important role.
Subject(s)
Aging , Hearing Loss/epidemiology , Hearing Loss/genetics , Adolescent , Adult , Age Factors , Aged , Aged, 80 and over , Child , Child, Preschool , Female , Genetic Predisposition to Disease , Geography , Hearing Loss/pathology , Humans , Infant , Italy/epidemiology , Male , Middle Aged , Pedigree , Prevalence , Quantitative Trait, Heritable , Young AdultABSTRACT
Hereditary hearing loss (HHL) is an extremely heterogeneous disorder with autosomal dominant, recessive, and X-linked forms. Here, we described an Italian pedigree affected by HHL but also prostate hyperplasia and increased ratio of the free/total PSA levels, with the unusual and extremely rare Y-linked pattern of inheritance. Using exome sequencing we found a missense variant (r.206A>T leading to p.Asp69Val) in the TBL1Y gene. TBL1Y is homologous of TBL1X, whose partial deletion has described to be involved in X-linked hearing loss. Here, we demonstrate that it has a restricted expression in adult human cochlea and prostate and the variant identified induces a lower protein stability caused by misfolded mutated protein that impairs its cellular function. These findings indicate that TBL1Y could be considered a novel candidate for HHL.